Clinical trial
Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage…
NCT00200525 · Mylan Bertek Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00200525 |
|---|---|
| Title | Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease |
| Official title | A Randomized, Placebo-Controlled Study of the Continued Efficacy and Safety of SC Apomorphine in the Treatment of Off Episodes in Patients With "On/Off" or "Wearing-Off" Effects Associated With Late-Stage PD After Apomorphine Use |
| Lead sponsor | Mylan Bertek Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | apomorphine HCl injection |
| Enrollment | 60 |
| Start date | Jul 1, 2001 |
| Completion | Jun 1, 2002 |
| First posted | Sep 20, 2005 |
| Last update posted | Dec 16, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: